Boustead Securities and ClickIPO Team Up to Bring the Soliton, Inc. (SOLY) IPO to Potential Subscribers Online with the Free ...
January 14 2019 - 3:00PM
via NEWMEDIAWIRE -- ClickIPO Securities, LLC
(“ClickIPO”) and Boustead Securities, LLC. (“Boustead”) announced
today that they are making the Soliton, Inc. (“SOLY”) Initial
Public Offering (“IPO”) available to eligible investors in
ClickIPO’s marketplace of IPOs.
Boustead clients and potential SOLY IPO
subscribers can now download the ClickIPO app free of charge from
the Apple App Store or Google Play store, and view the Soliton IPO
materials immediately through the app. “The ClickIPO app provides a
new opportunity for investors to participate in the SOLY IPO and
other Public Offerings,” said Dan McClory, Managing Director and
Head of Equity Capital Markets at Boustead. “As the Lead
Underwriter of Soliton IPO, we’re pleased to have ClickIPO clients
be part of Soliton’s NASDAQ Capital Market offering.”
Soliton, Inc., (NASDAQ: SOLY), a pre-revenue stage
medical device company with a new and proprietary platform
technology licensed from The University of Texas on behalf of the
MD Anderson Cancer Center, was qualified by the SEC for its $15
million maximum IPO at $5 per share on November 29, 2018. Soliton’s
patented Rapid Acoustic Pulse device uses acoustic shockwaves that,
in clinical trials, accelerated the speed of tattoo removal when
used with lasers, delivering results in as little as 2 to 3
treatments versus the 10 to 12 average with the current standard of
care lasers alone. The Company’s device is now also in clinical
trials to demonstrate its ability to reduce the appearance of
cellulite and accelerate subcutaneous fat reduction, indications
for which animal models have shown encouraging results. Clinical
trials may be in early stages and there is no guarantee of any
specific outcomes for any clinical trial.
The ClickIPO app for iOS and Android, available
through ClickIPO, allows eligible individual investors to
participate in certain Public Offerings. “We offer a simple
solution that enables the small investor to invest in available
offerings at the public offering price,” said Scott Coyle, CEO and
Founder of ClickIPO.
About Soliton, Inc.
Soliton, Inc. is a pre-revenue stage medical
device company with a new and proprietary platform technology
licensed from MD Anderson. The Company’s first commercial product
uses rapid pulses of designed acoustic shockwaves to accelerate the
removal of unwanted tattoos. The Company is based in Houston,
Texas, and is actively engaged in bringing this device to the
market. The Company expects to file for premarket clearance with
the U.S. Food and Drug Administration ("FDA") for its first device
in the first quarter of 2019 and expects to receive clearance to
market the device in mid 2019. This initial filing is limited to
the Company’s device used in conjunction with the 1064 nm
Q-switched laser to enable effective multiple pass laser treatments
in a single office session to accelerate removal of black tattoos
on the arms, legs and torso in Fitzpatrick Skin Type I-III
individuals. While the Company believes its technology has many
potential applications, the Company has initially focused on the
removal of tattoos, where both animal and human studies have shown
promising results. The current standard of care for tattoo removal
is to use a Q-switched (pulsed) laser to ablate the tattoo ink
particles into pieces small enough for the body’s natural processes
to remove them. The Company believes this current method is highly
inefficient, requiring up to 10 or more office visits to achieve
acceptable results. A clinical trial has demonstrated that using
the Company’s RAP device, in conjunction with a Q-switched laser,
has the potential to produce similar results in just 2 to 3 office
visits. The Company believes this “Soliton” method can not only
dramatically accelerate tattoo removal, but also has the potential
to lower removal cost for patients, while increasing profitability
to practitioners, and to reduce the potential for unwanted side
effects from current laser removal methods.
www.soliton.com
About Boustead Securities, LLC
Member: FINRA/SIPC
Boustead Securities, LLC is an investment banking
firm that advises clients on IPOs, mergers and acquisitions,
capital raises and restructuring assignments in a wide array of
industries, geographies and transactions. Our core value
proposition is our ability to create opportunity through innovative
solutions and tenacious execution. With experienced professionals
in the United States and around the world, Boustead's team moves
quickly and provides a broad spectrum of sophisticated financial
advice and services.
www.boustead1828.com
About ClickIPO
ClickIPO Securities, LLC exclusively offers the
mobile ClickIPO platform designed to give Individual Investors
access to hundreds of IPOs and Secondary Offerings each year. Its
technology gives Underwriters valuable insight into investor
behavior through the data it gathers and the app’s “ClickIPO
Investor Score”, providing a retail distribution channel similar to
dealing with institutions.
ClickIPO Securities, LLC is a broker dealer
registered with the SEC, and is a member of FINRA and SIPC.
ClickIPO Holdings, LLC is the parent company of Click IPO
Securities and owns the proprietary technology application known as
ClickIPO™. ClickIPO Holdings has granted Click IPO Securities an
exclusive and perpetual license to use the application and
authorization to relicense it for use by other registered broker
dealers. The application may not be available in some
jurisdictions.
The information posted on the ClickIPO website is
not an offer to sell or a solicitation of an offer to buy any
security, which can only be made by Prospectus, Offering Memorandum
or Information Statement. There can be no guarantee that an
investor will be allocated shares in any particular offering. Read
more information regarding the significant risks associated with
investing in IPOs.
Contact:
Dan McClory, Managing Director and Head of Equity Capital Markets
dan@boustead1828.com
+1 949 502 4408
Soliton (NASDAQ:SOLY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Soliton (NASDAQ:SOLY)
Historical Stock Chart
From Oct 2023 to Oct 2024